Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stigmatising Attitudes Towards People With Depression, Bipolar Disorder, Borderline Personality, ADHD and Early and Long-Term/Untreated Schizophrenia: Representative Survey of Australian Adults.

The Medical journal of Australia·2026
Same author

Vaccine Ligand Binding Assay Life Cycle Management, Assay Maintenance, Monitoring and Transfer.

Bioanalysis·2026
Same author

Experiences of discrimination and positive treatment among people who support a person with a mental health condition: a nationally representative survey.

Social psychiatry and psychiatric epidemiology·2026
Same author

A conserved dimerization element is required for protein kinase activation by <i>trans</i>-autophosphorylation.

bioRxiv : the preprint server for biology·2026
Same author

Stage-Specific Degradation of Cyclin D3 Orchestrates Myelopoiesis and Restrains Myeloproliferative Neoplasms Development.

Cancer research·2026
Same author

Mechanism of nucleolytic degradation of human ribosomes.

bioRxiv : the preprint server for biology·2026
Same journal

A simple, sensitive microsample LC-MS assay for quercetin and isorhamnetin in mouse and human plasma: application to EMIQ treatment in myotonic dystrophy type 1.

Bioanalysis·2026
Same journal

ADA assays for high-dose biologics: redefining drug tolerance through clinical insights.

Bioanalysis·2026
Same journal

Comparison of SERS spectral data sets of blood serum samples of hypopharyngeal cancer using silver and gold nanoparticles as substrates.

Bioanalysis·2026
Same journal

The Gyrolab platform for immunogenicity assessment and biotherapeutic and biomarker analysis: technical advances and bioanalytical applications.

Bioanalysis·2026
Same journal

Simultaneous quantification of D-penicillamine, D-penicillamine disulfide, and L-cysteine-D-penicillamine disulfide in human plasma: optimization of sample preparation and mass spectrometry procedures to support bioequivalence studies.

Bioanalysis·2026
Same journal

Development and preliminary clinical application of a time-resolved fluoroimmunoassay for anti-rituximab antibodies in membranous nephropathy.

Bioanalysis·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Recommendations on biomarker bioanalytical method validation by GCC.

Richard Hougton1, Dominique Gouty, John Allinson

  • 1Quotient Bioresearch, Fordham, UK.

Bioanalysis
|November 20, 2012
PubMed
Summary
This summary is machine-generated.

CRO leaders met at two GCC events to discuss and agree on recommendations for biomarker bioanalytical method validation. These discussions aimed to standardize and improve validation processes across the industry.

More Related Videos

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
07:43

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears

Published on: July 14, 2023

Related Experiment Videos

Last Updated: May 16, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
07:43

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears

Published on: July 14, 2023

Area of Science:

  • Biopharmaceutical Development
  • Analytical Chemistry
  • Clinical Research Operations

Background:

  • Biomarker bioanalytical method validation is critical for drug development.
  • Standardization of validation practices is needed across Contract Research Organizations (CROs).
  • Previous discussions have highlighted variability in current validation approaches.

Purpose of the Study:

  • To consolidate opinions and perspectives from CRO leaders on biomarker bioanalytical method validation.
  • To reach consensus on key recommendations for improving validation practices.
  • To foster harmonization in bioanalytical method validation across the industry.

Main Methods:

  • The study involved discussions and consensus-building among leaders from Contract Research Organizations (CROs).
  • Data was gathered through open sharing of opinions and perspectives at two Global CRO Council (GCC) events.
  • Recommendations were developed based on collective agreement during these meetings.

Main Results:

  • Agreement was reached on several key recommendations for biomarker bioanalytical method validation.
  • Identified areas of consensus include critical aspects of method validation.
  • The discussions facilitated a shared understanding of best practices among CRO leaders.

Conclusions:

  • The GCC events successfully brought together CRO leaders to address critical issues in bioanalytical method validation.
  • Consensus on recommendations is expected to drive standardization and enhance the quality of biomarker data.
  • These agreed-upon recommendations will serve as a valuable guide for the biopharmaceutical industry.